The values ​​to follow today on the Paris stock exchange – Friday, September 23, 2022

(AOF) – Akwell

Akwel, the supplier for the automotive and heavy goods vehicle industry, achieved consolidated revenue of 491 million euros in the first half of 2022, down very slightly compared to the first half of 2021 (487.6 million), but up 5% at constant scope and exchange rates, while global automotive production remained down over the period (-1.8%). Nevertheless, net income group share fell to 1.9 million, compared to 38 million in the first half of 2021. Financial income was -10 million, compared to -0.6 million a year ago.

Alten

Alten has unveiled a net income group share up 55.7% to 139 million euros in the first half. Operating profit on activity amounted to 208.6 million euros, up 52.1%. “The significant improvement in the activity rate, the strong growth of the international business, which is more profitable and the rigorous management of structural costs enabled the operating margin to increase to 11.4% despite the evolution of salaries (9 .8% in June 2021), “explains the engineering and technology consulting group.

Biosynex

The listing of Biosynex shares is suspended on Euronext at the company’s request, pending the publication of a press release and until further notice.

BOA-Concept

BOA Concept presented significantly improved accounts thanks to particularly dynamic activity: the net result amounted to 1.49 million euros, an increase of 77%. The current result almost doubled to 1.72 million euros compared to 0.86 million euros in the first half of 2021, The turnover of the specialist in intralogistics solutions jumped by 50% to 9 million euros .

EssilorLuxottica

EssilorLuxottica has announced the launch of a share buyback program of a maximum number of 1,500,000 EssilorLuxottica shares, depending on market conditions, over a period starting today, September 23, 2022 and which may extend until March 31, 2023.

Europlasma

Europlasma announced, following on from the press release of August 4 and in view of the consolidation work, that the estimated operating profit for the 1st half of 2022 is positive at €88,000 and that the estimated net profit group share is negative for 2.4 million euros. However, the latter is up by 8.7 million euros compared to the same period of the previous financial year.

Innate Pharma

Innate Pharma announced that its anti-KIR3DL2 antibody, lacutamab, has established clinical responses in patients with mycosis fungoides in the Phase 2 Tellomak trial.

L’OREAL

L’Oréal has signed an agreement to acquire Skinbetter Science, “American skincare brand at the forefront of dermatological research”. It achieved sales of more than $95 million over the rolling twelve months to July 31, 2022. “The brand’s growth is one of the strongest among prescribed skincare brands in the United States”, specifies the French firm.

Societe Generale

Societe Generale has announced the departure of Sadia Ricke, Chief Risk Officer of the group, as of November 30, 2022. “Guided by a personal and professional choice, Sadia Ricke is leaving the group for an opportunity in the banking sector in London”, specifies the bank. Societe Generale also announced the departure of Caroline Guillaumin, Director of Human Resources and Communication of the Societe Generale group as of December 15.

SQLI

SQLI reported a net profit of 2.6 million euros in the first half of the year, compared to 2.8 million euros in the first half of 2021. Current operating profit came to 11.2 million euros, compared to only 6.6 million euros, a year earlier. The margin improved by 3.2 points to 9%. At the end of June 2022, consolidated revenue thus reached 124.5 million euros, up 9.4%. At constant exchange rates and in the absence of a scope effect, billings were up 8%.

TF1

In the legal battle between it and Canal + concerning the non-broadcasting of its channels, the TF1 group regrets the decision of the judge in chambers of the Paris Commercial Court. The company owned by the Bouygues group believes that the judge “did not see the urgency of preserving the interests of viewers who use the TNTSAT service so that they are not – as the President of Arcom pointed out recently – held hostage to a commercial dispute that does not concern this service”.